https://www.selleckchem.com/products/apcin.html
© 2020 WILEY-VCH Verlag GmbH Co. KGaA, Weinheim.Programmed cell death-1 immune checkpoint inhibitor (ICI) antibody has proven to be effective in advanced non-small cell lung cancer (NSCLC) patients positive for programmed cell death-1 ligand-1. However, there are currently no reports which evaluate drug efficacy by continuous bronchoscopic observation. A 75-year-old man with complete right atelectasis was diagnosed with squamous cell carcinoma (SCC) of the right lower lobe (tumor proportion score TPS 90%, cT4N3M0, stage 3C). For fir
Like
Comment
Share
